Drugs License Approval: A Mandate for Good Manufacturing Practices by DCGI Commitment to Quality: Ensuring Pharmaceutical Excellence In an epoch-making move, the Drugs Controller General of India (DCGI) firmly positions itself in the advancement of drug safety. Aligning with a surge in the Indian pharmaceutical sector, currently boasting a $65 billion valuation, the key stipulation for licenses is enforcement. With a prominent spotlight on Good Manufacturing Practices (GMP), the DCGI underscores the critical nature of […]
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.